Key potential

Sergio Cifuentes: Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality

Sergio Cifuentes, Student Fellow at National Autonomous University of Mexico, shared on X:

“Maintenance Pembrolizumab for HER2- mBC.

– 43 women (32 TNBC): CR, PR, or SD after 3 cycles of chemotherapy,
– 4m DCR: 58.1%,
– mPFS: 4.8 m,
–  T-cell Clonality: PFS 10.4 vs. 3.6.

Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality.”

Proceed to the article.
Source: Sergio Cifuentes/X

Breast Cancer cancer HER2- mBC HER2-negative breast cancer National Autonomous University of Mexico OncoDaily Oncology pembrolizumab Sergio Cifuentes T-cell Clonality